- Home
- EKSO vs PSTV Comparison
EKSO vs PSTV Comparison
Compare EKSO & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EKSO
- PSTV
- Stock Information
- Founded
- EKSO 2005
- PSTV 1996
- Country
- EKSO United States
- PSTV United States
- Employees
- EKSO N/A
- PSTV N/A
- Industry
- EKSO Medical/Dental Instruments
- PSTV Medical/Dental Instruments
- Sector
- EKSO Health Care
- PSTV Health Care
- Exchange
- EKSO Nasdaq
- PSTV Nasdaq
- Market Cap
- EKSO 11.7M
- PSTV 10.4M
- IPO Year
- EKSO N/A
- PSTV N/A
- Fundamental
- Price
- EKSO $2.82
- PSTV $0.18
- Analyst Decision
- EKSO Strong Buy
- PSTV Strong Buy
- Analyst Count
- EKSO 2
- PSTV 3
- Target Price
- EKSO $37.50
- PSTV $13.00
- AVG Volume (30 Days)
- EKSO 238.2K
- PSTV 13.6M
- Earning Date
- EKSO 07-28-2025
- PSTV 08-13-2025
- Dividend Yield
- EKSO N/A
- PSTV N/A
- EPS Growth
- EKSO N/A
- PSTV N/A
- EPS
- EKSO N/A
- PSTV N/A
- Revenue
- EKSO $17,544,000.00
- PSTV $5,206,000.00
- Revenue This Year
- EKSO $0.20
- PSTV $13.26
- Revenue Next Year
- EKSO $42.29
- PSTV $8.84
- P/E Ratio
- EKSO N/A
- PSTV N/A
- Revenue Growth
- EKSO N/A
- PSTV N/A
- 52 Week Low
- EKSO $2.82
- PSTV $0.16
- 52 Week High
- EKSO $22.95
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- EKSO 20.84
- PSTV 29.61
- Support Level
- EKSO $3.75
- PSTV $0.16
- Resistance Level
- EKSO $4.03
- PSTV $0.36
- Average True Range (ATR)
- EKSO 0.35
- PSTV 0.04
- MACD
- EKSO -0.07
- PSTV -0.00
- Stochastic Oscillator
- EKSO 0.00
- PSTV 8.38
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).